Jian-Hong Zhong, Liang Ma, Bang-De Xiang, Da-Long Yang, Ai-Qun Liu, Ya-Qun Yu, Lin Ye, Shu-Qun Li, Shao-Ping Liu, Zhen Liu, Chuang Qin, Zhi-Jun Jiang, Ning Peng, Jia-Liang Wei, Ze Su, Jun-Liang Nong, Yi-He Yan, Kang Chen, Xiao-Feng Dong, Yong-Yu Yang, Jun-Jie Ou, Shu-Chang Chen, Ying Xue Wu, Hong-Bing Yao, Xue-Yao Wang, Fan-Jian Zeng, Jie Liu, Mian-Jing Li, Pei-Sheng Wu, Yong-Rong Liang, Yao-Zhi Chen, Yong-Cheng Lai, Ming-Song Wu, Wen-Feng Li, Tian-Man Li, Fu-Quan Yang, Zhi-Yin Liang, Teng-Meng Zhong, Xian-Shuang Mao, Fu-Xin Li, Teng-Xian Zhou, Guang-Cai Zheng, Yao-Ming Wang, Min Luo, Guo-dong Wang, Qing-Qing Pang, Xiao-Kai Shen, Lei Liu, Si-Cong Lu, Wen-Hai He, Xian-Jian Wu, Lin-Hong Xie, Jian-Yuan Meng, Zhi-Cheng Li, Ting Quan, Jin-Wei Wu, Ping Cen. "Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008)." Scientific Reports, 2026. doi:10.1038/s41598-026-53344-3